These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37607519)

  • 1. Hemolytic Uremic Syndrome-Induced Acute Kidney Injury Treated via Immunomodulation with the Selective Cytopheretic Device.
    Hambrick HR; Short K; Askenazi D; Krallman K; Pino C; Yessayan L; Westover A; Humes HD; Goldstein SL
    Blood Purif; 2023; 52(9-10):812-820. PubMed ID: 37607519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severely ill pediatric patients with Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS) who suffered from multiple organ involvement in the early stage.
    Luna M; Kamariski M; Principi I; Bocanegra V; Vallés PG
    Pediatr Nephrol; 2021 Jun; 36(6):1499-1509. PubMed ID: 33205220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).
    Khalid M; Andreoli S
    Pediatr Nephrol; 2019 Dec; 34(12):2495-2507. PubMed ID: 30382336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and Treatment for Shiga Toxin-Producing
    Liu Y; Thaker H; Wang C; Xu Z; Dong M
    Toxins (Basel); 2022 Dec; 15(1):. PubMed ID: 36668830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction during long-term follow-up in children with STEC hemolytic-uremic syndrome.
    Kreuzer M; Sollmann L; Ruben S; Leifheit-Nestler M; Fischer DC; Pape L; Haffner D
    Pediatr Nephrol; 2017 Jun; 32(6):1005-1011. PubMed ID: 28180952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute peritoneal dialysis, complications and outcomes in 389 children with STEC-HUS: a multicenter experience.
    Coccia PA; Ramírez FB; Suárez ADC; Alconcher LF; Balestracci A; García Chervo LA; Principi I; Vázquez A; Ratto VM; Planells MC; Montero J; Saurit M; Gutiérrez MGPY; Puga MC; Isern EM; Bettendorff MC; Boscardin MV; Bazán M; Polischuk MA; De Sarrasqueta A; Aralde A; Ripeau DB; Leroy DC; Quijada NE; Escalante RS; Giordano MI; Sánchez C; Selva VS; Caminiti A; Ojeda JM; Bonany P; Morales SE; Allende D; Arias MA; Exeni AM; Geuna JD; Arrúa L
    Pediatr Nephrol; 2021 Jun; 36(6):1597-1606. PubMed ID: 33394193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial).
    Freedman SB; Schnadower D; Estes M; Casper TC; Goldstein SL; Grisaru S; Pavia AT; Wilfond BS; Metheney M; Kimball K; Tarr PI;
    Trials; 2023 May; 24(1):359. PubMed ID: 37245030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
    Jenssen GR; Vold L; Hovland E; Bangstad HJ; Nygård K; Bjerre A
    BMC Infect Dis; 2016 Jun; 16():285. PubMed ID: 27297224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort.
    Monet-Didailler C; Godron-Dubrasquet A; Madden I; Delmas Y; Llanas B; Harambat J
    Pediatr Nephrol; 2019 Apr; 34(4):657-662. PubMed ID: 30368614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Genomics of Shiga Toxin-Producing Escherichia coli Strains Isolated from Pediatric Patients with and without Hemolytic Uremic Syndrome from 2000 to 2016 in Finland.
    Bai X; Ylinen E; Zhang J; Salmenlinna S; Halkilahti J; Saxen H; Narayanan A; Jahnukainen T; Matussek A
    Microbiol Spectr; 2022 Aug; 10(4):e0066022. PubMed ID: 35730965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study.
    Percheron L; Gramada R; Tellier S; Salomon R; Harambat J; Llanas B; Fila M; Allain-Launay E; Lapeyraque AL; Leroy V; Adra AL; Bérard E; Bourdat-Michel G; Chehade H; Eckart P; Merieau E; Piètrement C; Sellier-Leclerc AL; Frémeaux-Bacchi V; Dimeglio C; Garnier A
    Pediatr Nephrol; 2018 Aug; 33(8):1385-1394. PubMed ID: 29572749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga toxin-producing Escherichia coli hemolytic uremic syndrome.
    Peco-Antić A
    Srp Arh Celok Lek; 2016; 144(11-12):664-9. PubMed ID: 29659236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
    Bianchi L; Gaiani F; Vincenzi F; Kayali S; Di Mario F; Leandro G; De' Angelis GL; Ruberto C
    Acta Biomed; 2018 Dec; 89(9-S):153-157. PubMed ID: 30561409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome.
    Ylinen E; Salmenlinna S; Halkilahti J; Jahnukainen T; Korhonen L; Virkkala T; Rimhanen-Finne R; Nuutinen M; Kataja J; Arikoski P; Linkosalo L; Bai X; Matussek A; Jalanko H; Saxén H
    Pediatr Nephrol; 2020 Sep; 35(9):1749-1759. PubMed ID: 32323005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of Shiga toxin hemolytic uremic syndrome.
    Spinale JM; Ruebner RL; Copelovitch L; Kaplan BS
    Pediatr Nephrol; 2013 Nov; 28(11):2097-105. PubMed ID: 23288350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual severe case of hemolytic uremic syndrome due to Shiga toxin 2d-producing E. coli O80:H2.
    Wijnsma KL; Schijvens AM; Rossen JWA; Kooistra-Smid AMDM; Schreuder MF; van de Kar NCAJ
    Pediatr Nephrol; 2017 Jul; 32(7):1263-1268. PubMed ID: 28343354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
    Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diarrhoea-associated haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infections in New Zealand children: Clinical features and short-term complications from a 23-year cohort study.
    Wong W; Prestidge C; Dickens A; Ronaldson J
    J Paediatr Child Health; 2023 Mar; 59(3):493-498. PubMed ID: 36655863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume expansion mitigates Shiga toxin-producing E. coli-hemolytic uremic syndrome in children.
    Böckenhauer J; Schild R; Kemper MJ; Henne T; Stein MV; Oh J; Loos S
    Pediatr Nephrol; 2024 Jun; 39(6):1901-1907. PubMed ID: 38240870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Post-diarrheal haemolytic uremic syndrome: when shall we consider it? Which follow-up?].
    Bertholet-Thomas A; Ranchin B; King LA; Bacchetta J; Belot A; Gillet Y; Collardeau-Frachon S; Cochat P
    Arch Pediatr; 2011 Jul; 18(7):823-30. PubMed ID: 21571510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.